Alternative Epinephrine Delivery Method During Anaphylaxis for Pediatric Patients
This project has been secured to protect intellectual property.
Login for More InformationOral delivery method for epinephrine that will effectively counteract the symptoms of anaphylaxis in pediatric patients.
Design Award
- BME and UWSMPH-TECH Collaborative Innovation Award Winner
Project Overview
Anaphylaxis is caused by a hypersensitivity reaction to a benign antigen. These reactions can be very severe and need to be treated immediately. Although the occurrence of anaphylaxis is increasing for all ages, children of ages 5-9 are most commonly affected. Therefore, this project will focus on treatment of pediatric patients.
Current treatment methods for anaphylaxis include intramuscular epinephrine injection into the upper thigh of a patient. This which increases blood pressure and flow by increasing peripheral vascular resistance. This method involves the use of an EpiPen, a self-injectable applicator. Although the EpiPen is well known and commonly used, there are many factors that contribute to the need for an alternative administration method. Some of which include: high cost, high usage of expired EpiPens, failure to educate parents and subjects on how to properly use the device, fear of needles, and a very limited variety of doses.
The scope of this project includes developing a dissolving tablet to administer to children while they are experiencing anaphylactic shock. Benefits of this treatment method include easy administration, minimal required training, a longer shelf-life, direct administration into the bloodstream, and the opportunity to create a larger variety of doses to increase the efficiency of the drug.
Team Picture
Contact Information
Team Members
- Sophia Nehs - Team Leader
- Katarina Martinet - Communicator
- Alexus Edwards - BSAC
- Gwendolyn Johnson - BWIG
- Marisa Vattendahl Vidal - BPAG
- Alyssa Fleischman
- Grigor Simitian
Advisor and Client
- Prof. John Puccinelli - Advisor
- Dr. Lenard Markman - Client
Related Projects
- Spring 2023: Alternative epinephrine delivery method during anaphylaxis for pediatric patients
- Fall 2022: Alternative epinephrine delivery method during anaphylaxis for pediatric patients
- Spring 2022: Alternative epinephrine delivery method during anaphylaxis for pediatric patients
- Fall 2021: Alternative epinephrine delivery method during anaphylaxis for pediatric patients
- Spring 2021: Alternative Epinephrine Delivery Method During Anaphylaxis for Pediatric Patients
- Fall 2020: Alternative Epinephrine Delivery Method During Anaphylaxis for Pediatric Patients
- Spring 2020: Alternative Epinephrine Delivery Method During Anaphylaxis for Pediatric Patients